Novescia

Consolidation ahead

Following the landmark transaction by which Novescia acquired the biology pole of Générale de Santé at the end of 2009, the Company continues to actively participate in the gradual consolidation of the fragmented private lab market in France. The latter is driven by multiple factors, including the compulsory certification of medical labs, an increasing number of biologists nearing retirement age and facing succession issues, continuing cost pressure in the industry, etc. Although still at the beginning of such consolidation phase taking place in France, all signs point in that direction. 

Efficient partnership

Novescia is implementing an ambitious growth strategy consisting of acquiring labs in defined geographical areas in France, and centralising on technical platforms the medical analyses formerly performed within the individual entities. Novescia’s innovative business model comprises a true partnership with biologists and an industrial approach focused on both quality and efficiency of operations.

Minority shareholder

As from July 2010, Cobepa acts as a minority shareholder holding a 10% stake in Novescia.